Ondansetron Injection, Solution
Product Images NDC 0409-0009

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 0409-0009). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ondansetron 01)

Chemical structure of Ondansetron, depicted with its heterocyclic rings including indole and imidazole moieties, illustrating the arrangement of carbon, nitrogen, oxygen atoms, and associated chemical bonds as part of its molecular formula with hydrochloride and dihydrate components.*

FDA Label Image

Logo (Ondansetron 02)

FDA Label Image

Principal Display Panel (2 mL Vial Label)

Ondansetron Injection, USP 4 mg/2 mL (2 mg/mL) vial label for a 2 mL single-dose vial. The label indicates the product is distributed by Hospira, Inc., Lake Forest, IL, USA, and is for prescription use only. It includes a barcode and lot details on the side.*

FDA Label Image

Principal Display Panel (2 mL Vial Carton)

Ondansetron Injection, USP 4 mg/2 mL (2 mg/mL) sterile solution label for 25 single-dose fliptop vials. The label shows storage instructions, active ingredient details, NDC 0409-0009-25, bar code, and distribution by Hospira, Inc. It is indicated for intramuscular or intravenous use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.